What precautions should be taken while taking regorafenib?

Regorafenib is a multi-target tyrosine kinase inhibitor that is widely used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors, hepatocellular carcinoma and other diseases. When patients take regorafenib, they usually follow a cyclical schedule, such as taking the drug for three weeks followed by one week off. In order to ensure the best effect of the drug, patients should take it at the same time every day, after meals. It is usually recommended to swallow the tablet whole with warm water within 1 hour after a low-fat diet. Do not chew or break it.

While taking the medication, patients need to pay special attention to monitoring liver function, blood pressure and skin conditions. Regorafenib may cause liver function abnormalities, so liver function tests should be performed before and regularly during treatment. Some patients may also experience adverse reactions such as high blood pressure and hand-foot syndrome (redness, swelling, peeling, and pain on the hands and feet). If symptoms occur, they must inform their doctor in time. If necessary, adjust the dosage or discontinue the drug for a short period of time to avoid affecting physical health and the treatment process.

In addition, patients should avoid taking drugs that may interact with regorafenib at the same time, such as certain antifungal drugs, antibiotics, anti-epileptic drugs, etc. These drugs may affect the metabolism rate of regorafenib in the body, thereby reducing the efficacy or increasing the risk of toxic side effects. Grapefruit juice should also be avoided because components in grapefruit may inhibit the metabolism of regorafenib. If you need to add other drugs during the medication, you must communicate with your doctor in advance and handle it with caution.

Finally, while taking regorafenib, patients should maintain adequate fluid intake, arrange rest appropriately, reduce strenuous exercise, avoid trauma, and pay special attention to skin care when symptoms of hand-foot syndrome occur. If obvious discomfort occurs, such as persistent diarrhea, severe fatigue, bleeding tendency or other serious reactions, the drug should be stopped immediately and seek medical treatment. Standardized monitoring and management can help improve the safety and effectiveness of regorafenib treatment.

Reference materials:https://www.stivarga-us.com/